<SEC-DOCUMENT>0001104659-19-008799-index.html : 20190214
<SEC-HEADER>0001104659-19-008799.hdr.sgml : 20190214
<ACCEPTANCE-DATETIME>20190214164811
ACCESSION NUMBER:		0001104659-19-008799
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20190214
DATE AS OF CHANGE:		20190214
GROUP MEMBERS:		HBM BIOCAPITAL INVEST LTD.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics plc
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89113
		FILM NUMBER:		19607649

	BUSINESS ADDRESS:	
		STREET 1:		56 FITZWILLIAM SQUARE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		(610) 816-6640

	MAIL ADDRESS:	
		STREET 1:		1000 CONTINENTAL DRIVE
		STREET 2:		SUITE 600
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nabriva Therapeutics AG
		DATE OF NAME CHANGE:	20150507

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HBM Healthcare Investments (Cayman) Ltd.
		CENTRAL INDEX KEY:			0001232258
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		2454 WEST BAY ROAD, 3RD FLOOR
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			00000
		BUSINESS PHONE:		1 345 946 8002

	MAIL ADDRESS:	
		STREET 1:		P.O BOX 30852
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1204

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HBM BIOVENTURES CAYMAN LTD
		DATE OF NAME CHANGE:	20030512
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>a19-4663_1sc13ga.htm
<DESCRIPTION>SC 13G/A
<TEXT>
Document 1 - file: a19-4663_1sc13ga.htm

</DOCUMENT>
</SEC-DOCUMENT>